中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月3日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2024, Vol. 31 Issue (15): 90-93转98    
  中西医结合研究 本期目录 | 过刊浏览 | 高级检索 |
中药浸浴联合重组表皮细胞在压疮患者中的应用效果
颜廷荣 程小平 高明龙 陈黎明 李雪红 毛 智
江西省贵溪市中医院护理部,江西贵溪 335400
Application effect of traditional Chinese medicine soaking combined with recombinant epidermal cells in pressure ulcer patients
YAN Tingrong CHENG Xiaoping GAO Minglong CHEN Liming LI Xuehong MAO Zhi
Department of Nursing,Guixi Traditional Chinese Medicine Hospital,Jiangxi Province,Guixi 335400,China
全文: PDF (530 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究中药浸浴联合重组表皮细胞在压疮患者中的应用效果。方法 选取2022 年1 月至2023 年6 月贵溪市中医院收治的60 例压疮患者作为研究对象,采用随机数字表法将其分为对照组与观察组,每组各30 例。对照组采用重组表皮细胞生长因子方法,观察组在对照组基础上使用中药浸浴,分析两组干预后的创面愈合有效率、炎症因子水平、症状缓解时间、转化生长因子(TGF-β1)、血管内皮生长因子(VEGF)表达水平以及不良反应发生率。结果 治疗前两组的TGF-β1、VEGF 表达水平、炎症因子水平比较,差异无统计学意义(P>0.05)。观察组治疗后TGF-β1、VEGF 表达水平以及炎症因子水平均低于对照组,差异有统计学意义(P<0.05)。观察组症状缓解时间、不良反应发生率低于对照组,差异有统计学意义(P<0.05)。观察组创面愈合总有效率高于对照组,差异有统计学意义(P<0.05)。结论 在临床上对压疮创面修复中采用重组表皮细胞生长因子联合中药浸浴效果更好,患者创面愈合有效率提高,症状缓解时间缩短,不良反应发生率少,安全性高且效果显著,临床应用价值高。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 重组表皮细胞生长因子中药浸浴压疮症状缓解时间创面愈合有效率    
Abstract:Objective To explore the application effect of traditional Chinese medicine soaking combined with recombinant epidermal cells in patients with pressure ulcers.Methods Sixty patients with pressure ulcers admitted to Guixi Traditional Chinese Medicine Hospital from January 2022 to June 2023 were selected as the study subjects.They were divided into control group and observation group using the random number table method,with 30 cases in each group.The control group was treated with recombinant epidermal growth factor method,while the observation group was treated with traditional Chinese medicine soaking on the basis of the control group.The effective rate of wound healing,inflammatory factor levels,symptom relief time,and transforming growth factor-β1(TGF-β1)of the two groups after intervention were analyzed.The expression level of vascular endothelial growth factor(VEGF)and the incidence of adverse reactions.Results The comparison of TGF-β1,VEGF expression level and inflammatory factor level of the two group before treatment showed no statistically significant differences(P>0.05).After treatment,the expression levels of TGF-β1,VEGF and inflammatory factors of the observation group were lower than those of the control group,and the differences were statistically significant (P<0.05).The symptom relief time and incidence of adverse reactions in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The total effective rate of wound healing in the observation group was higher than that in the control group,and the difference was statistically significant (P<0.05).Conclusion In clinical practice,the use of recombinant epidermal growth factor combined with traditional Chinese medicine soaking is more effective in repairing pressure ulcer wounds.The total effective rate of wound healing in patients is improved,the time for symptom relief is shortened,the incidence of adverse reactions is low,the safety is high,and the effect is significant.The clinical application value is high.
Key wordsRecombinant epidermal cell growth factor    Traditional Chinese medicine soaking    Pressure ulcer    Symptom relief time    Effective rate of wound healing
    
基金资助:江西省中医药管理局科技计划项目(2023B0980)。
引用本文:   
颜廷荣; 程小平; 高明龙; 陈黎明; 李雪红; 毛 智. 中药浸浴联合重组表皮细胞在压疮患者中的应用效果[J]. 中国当代医药, 2024, 31(15): 90-93转98.
YAN Tingrong CHENG Xiaoping GAO Minglong CHEN Liming LI Xuehong MAO Zhi. Application effect of traditional Chinese medicine soaking combined with recombinant epidermal cells in pressure ulcer patients. 中国当代医药, 2024, 31(15): 90-93转98.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2024/V31/I15/90
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载